chartexchange

EQ
Equillium, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
1.09USD-9.917%(-0.12)889,918
Pre-marketNov 18, 2026 9:29:30 AM EST
1.10USD-9.091%(-0.11)
After-hoursNov 18, 2026 4:25:30 PM EST
1.10USD+0.917%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Jolla, CA, USA
Previous Close
$1.21
Beta
1.35
52-Week High
$3.54 2026-06-30
52-Week Low
$0.81 2025-12-03
SMA 50
$1.52
SMA 200
$2.08
Avg. Vol 10D
379,605
Avg. Vol 30D
471,756
Avg. Vol 90D
526,885
Relative Vol
1.89
47.89M
3.7100%
3,700,000
3,160
EQ Profile

equillium, inc., a clinical-stage biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor cd6, which is in phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and phase 1 clinical trial for the treatment of asthma and lupus nephritis. the company was formerly known as attenuate biopharmaceuticals, inc. and changed its name to equillium, inc. in may 2017. equillium, inc. was founded in 2017 and is headquartered in la jolla, california.

EQ Performance
PeriodPriceDateChangeBeta
1W1.322026-11-12-17.42%2.251
1M1.242026-10-19-12.10%1.856
3M2.332026-08-19-53.22%1.472
6M1.772026-05-19-38.24%1.167
1Y1.012025-11-19+7.92%1.353
2Y0.702024-11-19+55.71%—
5Y5.252021-11-19-79.24%0.751
EQ Stock Summary

Equillium, Inc. Common Stock (NASDAQ:EQ) stock price today is $1.09, and today's volume is 889,918. EQ is down 9.917% today. The 30 day average volume is 471,756. EQ market cap is $89.73M with 82.32M shares outstanding.